ECIA ENCISION INC Insider Trading

CEO Robert H Fries buys 166,785 shares in 2 tranches for $24,024.90; prior buys at ECIA showed +256.0% and +11.4% 90d returns

Robert H Fries, CEO of Encision Inc, made two separate purchases totaling 166,785 shares (166.8K shares) for $24,024.90 on April 15–16, 2026, at prices of $0.14 and $0.20, increasing his holdings by 12.4% to 1,506,785 shares (1.51M shares). His prior open-market buys at ECIA showed strong 90-day outcomes: +256.0% on 2025-08-19 and +11.4% on 2024-08-29, with both trades well-timed (positive returns following purchase). His cross-ticker track record shows 2 prior buys with an average 90-day return of +74.5% and a 100% win rate. However, current fundamentals are deteriorating: the company reported revenue of $1,528,050.00 (latest quarter), net income of $-267,833.00, annual revenue growth of -0.5%, and remains unprofitable on a full-year basis. The current price of $0.20 is down -50.0% from the 52-week high, though up +53.8% over the past 30 days. The divergence between the CEO's historical buy timing acumen and the company's negative earnings trajectory presents conflicting signals for investors to reconcile.

10% owner CMED PARTNERS LLLP bought 2,000,000 shares of ECIA.PK at $0.10; post-transaction holdings 5,196,249 shares (+62.6%)

CMED PARTNERS LLLP, a 10% owner of Encision Inc, purchased 2,000,000 shares at $0.10 for $200,000.00 on 2025-08-19, increasing holdings by 62.6% to 5,196,249 shares. This transaction occurs within a cluster pattern: 3 other insiders also bought within the past 14 days. The company is unprofitable with net income of $-41,133.00 over its most recent full fiscal year, though latest quarterly revenue stands at $1,602,728.00 with annual revenue growth of -0.5%. The synchronized buying activity among multiple insiders at a depressed sub-$0.10 valuation, coupled with the company's thin profitability profile, suggests coordinated accumulation at a price point insiders view as materially undervalued, though the negative revenue trajectory and operating losses introduce material risk to the underlying thesis.

Director Fries buys 35,000 shares of ECIA at $0.37; holds 590,000 post-transaction while company faces -10.4% revenue decline and full-year losses.

Robert H. Fries, a Director, purchased 35,000 shares at $0.37 on 2024-08-29, bringing his total holdings to 590,000 shares, a 6.3% increase relative to his pre-transaction position. The stock was trading at -50.7% from its 52-week high of $0.75, though it had gained 5.7% over the preceding 30 days. Encision Inc reported annual revenue decline of -10.4% and was unprofitable over its most recent full fiscal year, with latest-quarter revenue of only $1.6M and net income of just $22.0K. This purchase by a board member occurs against a backdrop of deteriorating fundamentals, though the recent 30-day upward price movement may have influenced the timing. The modest share acquisition and company's micro-cap status ($4.4M market cap) suggest limited institutional visibility for this transaction.

CEO Trudel Gregory J. buys 3,300 shares (3.3K) of ECIA at $0.32; stock -57.3% from 52-week high, company unprofitable full-year.

CEO Trudel Gregory J. purchased 3,300 shares at $0.32, representing a 1.1% increase to his 297.8K share holdings. The purchase occurs within a materially distressed price context: the stock trades -57.3% from its 52-week high of $0.75 and has declined -36.0% over the past 90 days. The company's financial trajectory is concerning—annual revenue declined -10.4% year-over-year, the company posted a net loss in its most recent full fiscal year, and current quarter net income of $22.0K on quarterly revenue of $1.6M indicates minimal profitability. The combination of steep price decline, deteriorating financial metrics, and unprofitable full-year results creates an inherent tension that makes the purchase signal ambiguous; while insider buying at depressed levels can indicate confidence, it occurs within a backdrop of operational distress that warrants investor scrutiny.